Esperion Therapeutics, Inc. (ESPR)
3.855
-0.22
(-5.51%)
USD |
NASDAQ |
Dec 12, 16:00
3.88
+0.02
(+0.65%)
After-Hours: 20:00
Esperion Therapeutics Research and Development Expense (Annual): 46.24M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 17.26B |
| Ovid Therapeutics, Inc. | 36.37M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |
| Theriva Biologics, Inc. | 12.03M |